Additional BCR-ABL1 Mutations Identified By Sensitive Mass Spectrometry In Chronic Phase CML Patients With T315I Treated With Ponatinib Are Associated With Relatively Inferior Responses and Outcome

被引：0

作者：

Parker, Wendy T.

Yeoman, Alexandra L.

Altamura, Haley

Roberts, Nicola

Yeung, David T.

Jamison, Bronte A.

Field, Chani

Lustgarten, Stephanie

Hodgson, Graeme

Rivera, Victor M.

Hughes, Timothy P.

Branford, Susan

机构：

来源：

关键词：

D O I：

10.1182/blood.V122.21.651.651

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

651

引用

页数：2